WallStreetZenWallStreetZen

NASDAQ: LRMR
Larimar Therapeutics Inc Stock Ownership - Who owns Larimar Therapeutics?

OverviewForecastEarningsDividendOwnership

Insider buying vs selling

Have Larimar Therapeutics Inc insiders been buying or selling?
Buy
Sell
NameRoleDateSharesPriceValue
James E. FlynnDirector2024-02-161,430,205$8.74
$12.50MBuy
James E. FlynnDirector2024-02-161,430,206$8.74
$12.50MBuy
James E. FlynnDirector2024-02-161,430,206$8.74
$12.50MBuy
Frank E. ThomasDirector2024-02-142,000$11.00
$22.00kBuy
Gopi ShankarChief Development Officer2023-12-075,000$3.73
$18.66kBuy
Joseph TruittDirector2023-05-172,750$3.73
$10.26kBuy
Michael CelanoChief Financial Officer2023-05-175,000$3.73
$18.63kBuy
Carole BenmaimonPresident and CEO2023-05-175,000$3.71
$18.53kBuy

1 of 1

LRMR insiders have bought more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when LRMR insiders and whales buy or sell their stock.

LRMR Shareholders

What type of owners hold Larimar Therapeutics Inc stock?
Institutional
Insider
Retail
NameHoldSharesValueType
James E. Flynn45.13%28,789,915$188.00MInsider
Deerfield Management Company LP Series C26.55%16,941,357$110.63MInstitution
Peter Barrett16.11%10,276,057$67.10MInsider
Bruce Booth16.10%10,270,758$67.07MInsider
Blue Owl Capital Holdings LP5.35%3,414,468$22.30MInstitution
Verition Fund Management LLC4.41%2,811,131$18.36MInstitution
Deerfield Partners LP4.35%2,777,777$18.14MInsider
Janus Henderson Group PLC4.14%2,641,065$17.25MInstitution
Blackrock Inc2.61%1,668,045$10.89MInstitution
Vanguard Group Inc2.28%1,455,243$9.50MInstitution

1 of 3

LRMR vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
LRMR42.05%57.95%Net BuyingNet Buying
ANNX76.31%23.69%Net BuyingNet Selling
VYGR47.14%52.86%Net SellingNet Selling
CDMO90.48%9.09%Net Selling
TRML43.00%57.00%Net SellingNet Buying
View Top Biotech Stocks

Larimar Therapeutics Stock Ownership FAQ

Who owns Larimar Therapeutics?

Larimar Therapeutics (NASDAQ: LRMR) is owned by 61.84% institutional shareholders, 85.23% Larimar Therapeutics insiders, and 0.00% retail investors. James E. Flynn is the largest individual Larimar Therapeutics shareholder, owning 28.79M shares representing 45.13% of the company. James E. Flynn's Larimar Therapeutics shares are currently valued at $184.26M.

If you're new to stock investing, here's how to buy Larimar Therapeutics stock.
©2024 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.